status Canada Since 2012, TFMPP has been listed as a Schedule III controlled substance in Canada, making possession of TFMPP a federal offence. It has also been added to Part J of the Food and Drug Regulations thereby prohibiting the production, export or import of the substance. China As of October 2015 TFMPP is a controlled substance in China. Denmark As of December 3, 2005, TFMPP is illegal in Denmark. Japan Since 2003, TFMPP and BZP became illegal in Japan. Netherlands TFMPP is unscheduled in the Netherlands. New Zealand Based on the recommendation of the EACD, the New Zealand government has passed legislation which placed BZP, along with the other piperazine derivatives TFMPP, mCPP, pFPP, MeOPP and MBZP, into Class C of the New Zealand Misuse of Drugs Act 1975. A ban was intended to come into effect in New Zealand on December 18, 2007, but the law change did not go through until the following year, and the sale of BZP and the other listed piperazines became illegal in New Zealand as of 1 April 2008. An amnesty for possession and usage of these drugs remained until October 2008, at which point they became completely illegal. Sweden As of March 1, 2006, TFMPP is scheduled as a "dangerous substance" in Sweden. Switzerland As of December 1, 2010, TFMPP is a controlled substance in Switzerland. United Kingdom As of December 2009, TFMPP has been made a Class C drug in the United Kingdom along with BZP. United States TFMPP is not currently scheduled at the federal level in the United States, but it was briefly emergency scheduled in Schedule I. The scheduling expired in April 2004 and was not renewed. However, some states such as Florida have banned the drug in their criminal statutes making its possession a felony. Florida TFMPP is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in Florida. Texas TFMPP is scheduled in Texas under Penalty Group 2, as a hallucinogenic substance. It is illegal to possess TFMPP in any quantity in Texas. Derivatives Antrafenine CPD-1 See also Substituted piperazine References External links Erowid: TFMPP Vault Designer drugs Trifluoromethyl compounds Phenylpiperazines Serotonin receptor agonists Serotonin releasing agents meta-Trifluoromethylphenylpiperazines